C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,720,000 | +16.3% | 766,231 | 0.0% | 0.20% | +7.7% |
| Q2 2022 | $5,777,000 | -88.6% | 766,231 | -63.2% | 0.18% | -82.1% |
| Q1 2022 | $50,526,000 | -64.5% | 2,082,723 | -52.9% | 1.01% | -7.7% |
| Q4 2021 | $142,252,000 | +41.0% | 4,417,826 | +95.6% | 1.10% | -25.2% |
| Q3 2021 | $100,913,000 | -41.0% | 2,258,566 | -50.0% | 1.47% | +32.1% |
| Q2 2021 | $170,928,000 | +46.3% | 4,517,132 | +43.0% | 1.11% | -24.8% |
| Q1 2021 | $116,835,000 | +11.7% | 3,158,566 | 0.0% | 1.48% | +31.5% |
| Q4 2020 | $104,643,000 | – | 3,158,566 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |